Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Nan H, Kraft P, Hunter DJ, Han J
Phase I awards are up to $250,000 for 9 months
In February, based on early results of promising anti-tumor activity and manageable safety profile from a Phase I study, the FDA granted Fast Track Designation to CUSP06, a Cadherin-6 ADC employing exatecan as the payload, for the treatment of PROC
And the side effect comparison between the two medications helps you weigh tolerance factors that might favor one over the other
So, by combining those seven, when you're done reading the book, you've basically cleaned up all major bodily systems in your body, and you're going to improve
US$ 21.34
US$ 24.19
US$ 23.17
US$ 21.88
US$ 25.35
US$ 22.71
US$ 26.14
